Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

NCT06069570 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung Cancer
Bone Metastases From Solid Tumors

Interventions

BIOLOGICAL: KB-GDT-01

Sponsor

Kiromic BioPharma Inc.

Collaborators

[object Object]